The TYROBP gene gives cells instructions for a signaling helper used by certain immune cells, cells that help protect the brain, and bone cells. This gene helps your body coordinate signals involved in clearing debris, managing inflammation, and normal bone turnover. If it does not work properly, rare inherited conditions can affect both bones and the brain, sometimes causing bone cysts, fractures, and later changes in movement, behavior, or memory.
What is a gene?
Genes are segments of DNA that carry instructions your cells use to make molecules or regulate processes throughout the body. Some genes provide the information needed to produce proteins, the parts of cells that do much of the work. Other genes mainly help regulate when certain processes take place, where they occur, and how strongly they operate. Together, genes influence how the body develops and functions, and they can affect how you respond to food, stress, or medications. To go further into this topic, you can find more in LearnHub.
Overview
TYROBPGene function
What if the gene works
The TYROBP gene helps certain immune cells, including immune cells in the brain, pass signals. This supports cleanup of debris, immune responses, and normal bone remodeling.
Risk
What if the gene does not work
When the TYROBP gene does not work properly, it can cause a condition with bone cysts, fractures, and progressive brain changes that affect thinking and movement. Milder or severe variants can influence when symptoms begin and how pronounced they are.
Treatment
What does that mean for your treatment
No TYROBP-specific treatment or management approach is currently established. The TYROBP gene is being studied as a marker and possible drug target in brain immune pathways, especially in neurodegenerative disease, but this has not changed routine treatment.
Conditions associated with TYROBP
Gene function
What if the gene works
Many of your immune cells use the TYROBP gene to relay messages from their surface to the cell interior. This helps microglia, macrophages, natural killer cells, and bone remodeling cells coordinate routine jobs. Understanding how the TYROBP gene helps immune cells communicate makes its role in brain, immune, and bone health easier to picture.
Inside certain immune cells, the TYROBP gene acts as a signaling partner for receptors on the cell surface. When those receptors detect a cue, this gene helps pass that message inward so the cell can respond in an organized way.
In microglia (the brain’s cleanup cells) and macrophages, the TYROBP gene supports the safe clearance of cell debris and worn out material. This helps tissues stay tidy and lets the immune system handle routine cleanup as part of normal maintenance.
The TYROBP gene helps natural killer cells, a type of immune cell, adjust their activity when they meet nearby cells. Its signals help balance when to engage, when to hold back, and how strongly to respond.
Bone remodeling cells use the TYROBP gene during the steady process of removing older bone so new bone can replace it. This supports normal bone turnover, which helps keep the skeleton renewed over time.
What is a variant?
A genetic variant is a small alteration in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants have no noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change a gene’s function more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Changes in the TYROBP gene can reduce or stop production of the DAP12 protein, or make it harder for this protein to link with partner receptors and pass signals inside brain immune cells and bone-resorbing cells. Understanding how TYROBP gene variants affect protein function helps explain why some variants have a mild effect while more disruptive variants can greatly weaken or nearly abolish signaling. When both gene copies are severely affected, TYROBP-related disease often starts earlier and may be more pronounced.
How variants are linked to conditions
Pathogenic variants in the TYROBP gene cause a rare inherited condition called polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy, also known as Nasu-Hakola disease. This TYROBP gene variant condition usually involves bone cysts and fractures in early adulthood, followed later by changes in memory, behavior, and thinking. TYROBP-related disease is rare and is mainly linked to this specific diagnosis rather than a wide range of common health conditions.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widely found across the general population. Most do not have a direct impact on health and instead represent natural differences among people. For many genes, having a variant associated with a condition suggests a possible link rather than a firm diagnosis, especially when several genes and environmental factors contribute. In some situations, though, a single well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the TYROBP gene. For families with a known TYROBP change, personal risk mainly depends on the exact genetic finding and family history, and a doctor or genetic counselor can help explain what that means.
Inheritance of TYROBP variants
TYROBP-related disease is inherited in an autosomal recessive pattern. This means a person usually develops the condition only if they inherit two nonworking copies of the TYROBP gene, one from each parent. Parents who each carry one TYROBP variant are typically unaffected carriers, and with each pregnancy there is a 25% chance for an affected child, a 50% chance for a carrier child, and a 25% chance for a child without the familial variants. In practical terms, how TYROBP variants are inherited depends on both parents passing on the changed copy.
What does my TYROBP result mean for my family?
For TYROBP, the main well-established family pattern is recessive, which usually means parents are healthy carriers and brothers or sisters may also be carriers or, less often, have the same condition. Close relatives may want to learn whether this result is relevant in their branch of the family, especially if there is a history of early memory decline or bone problems. The meaning for children depends on whether the other parent also carries a TYROBP change.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for variants in the TYROBP gene usually uses a blood or saliva sample. A lab reads the gene’s DNA code to look for changes and reports whether a variant is found, not found, or needs more interpretation. This can help clarify whether TYROBP-related findings fit a known inherited condition.
When should I consider getting a genetic test?
Genetic testing for the TYROBP gene may be worth considering if you or a close relative has a rare inherited pattern of repeated bone fractures or bone cysts along with early memory, thinking, or behavior changes. It can help confirm the cause and clarify whether other family members may also carry the gene change.
A genetic result is only one part of your health story
Genetic test results can provide useful insight, yet how much they reveal varies by the condition and the type of variant involved. Over time, how the body works is also shaped by factors such as lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas such as medication response, these results may also help make sense of individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the body, or responds to it at its target, so the same treatment may work better for one person than another. These differences are common and can influence how much benefit a medicine gives or how sensitive someone is to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes can affect the way people respond to medicines. It studies gene drug relationships to help explain why the same treatment may not work in the same way for everyone. With many medications, genes can influence either how powerfully a drug works or how the body handles it. This information can support treatment choices that are better informed and more individualized. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the TYROBP gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so questions about symptoms, side effects, or how medicines may affect you are best discussed with your doctor. Seek medical advice promptly if a new medicine seems to cause problems or if your health changes while taking treatment.
History
Throughout history, people have described features that hinted at this gene. In the 1970s and 1980s, doctors in Finland and Japan carefully documented families with a rare inherited condition causing bone cysts and early changes in thinking and behavior, later called polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy, or Nasu-Hakola disease. From these first observations, research expanded steadily. Around 2000, researchers identified variants in the TYROBP gene as one cause of this condition, alongside variants in the TREM2 gene. That finding helped connect clinical observations from different countries into a clearer genetic picture. Over time, the TYROBP gene also became part of broader research into brain immune cells and neurodegenerative disease.